You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Researchers have been using Nextstrain, which includes data for thousands of SARS-CoV-2 genomes, to study how the virus accrues mutations over time.
In PNAS this week: strategies to design DNA oligonucleotide probes for bacteria, Vibrio cholerae evolution in Haiti, and more.
In PNAS this week: cell line to assay myotonic dystrophy type 1 therapies, gene involved in rice architecture, and more.
In PNAS this week: C2CD4A gene involved in insulin secretion, chromosome rearrangements in recurring S. aureus infections, and more.
Scientists take measures to protect against the effects of Hurricane Dorian, ScienceInsider reports.
The trials are part of the second phase of the Implementing Genomics in Practice program, which is slated to receive $42 million in funding over 5 years.
In PLOS this week: Madariaga virus linked to pediatric acute febrile illness cases in Haiti, tool to screen for viral infection in human cell lines, and more.
DiaCarta scientists will partner with the University of Florida Health Cancer Center to analyze blood samples from up to 500 cancer patients undergoing radiotherapy.
In PLOS this week: Huntington's disease modifiers, possible new Chikungunya virus subgroup, and more.
The funding will support research examining the epigenomic effects of social experiences and how they relate to health disparities.
The Lancet has made changes to its peer-review process in response to its recent retraction of a COVID-19-related paper, Science reports.
The New York Times reports that a series of emails show how Department of Health and Human Services officials sought to silence the Centers for Disease Control and Prevention.
A new initiative aims to move Australia's genome sequencing labs onto one system, the Sydney Morning Herald reports.
In PLOS this week: recessive mutation tied to early-onset dilated cardiomyopathy, epigenetic analysis of lung adenocarcinoma, and more.